Esperion Announces Positive Phase 2 Clinical Trial Results for ETC-1002Esperion Therapeutics, a privately held biotechnology company in Plymouth, Monday announced positive results from a Phase 2 clinical trial for its potential cholesterol buster, ETC-1002.

More From CBS Detroit

Best Places For Paczki In DetroitFat Tuesday is less than a week away! Here's where to find the best paczki in town.
Best Ice Cream Shops In Metro DetroitIt's getting warm outside! Take advantage of it.
Best Hiking Trails In Metro DetroitGet out there and enjoy this unseasonably warm weather!

Watch & Listen